Experts Predict IVOV Will Reach $116
ETF Analysis: The Vanguard S&P Mid-Cap 400 Value ETF (IVOV) has an implied analyst target price of $115.73, indicating a potential upside of 17.24% from its current trading price of $98.71.
Notable Holdings: Key underlying holdings with significant upside potential include MP Materials Corp (48.03% upside), Rayonier Inc. (35.84% upside), and Gentex Corp. (29.76% upside) based on their respective analyst target prices.
Market Sentiment: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets may lead to future downgrades if they do not align with market realities.
Investor Considerations: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Trade with 70% Backtested Accuracy
Analyst Views on GNTX
About GNTX
About the author

- Sales Performance Growth: Gentex reported consolidated net sales of $644.4 million in Q4, with VOXX contributing $103.4 million and core Gentex revenue at $541 million, demonstrating strong performance in primary markets despite a 2% decline in light vehicle production, with a 3% revenue growth indicating resilience.
- Margin Improvement: The consolidated gross margin for Q4 was 34.8%, with core Gentex gross margin at 35.5%, reflecting a 300 basis point increase from last year and marking the highest level since the first half of 2021, showcasing successful improvements in product mix and operational efficiencies.
- Share Buyback Program: Gentex repurchased 3.8 million shares in Q4 at an average price of $23.43, totaling 13.6 million shares for the year at $319 million, underscoring the company's confidence in its stock value and commitment to shareholders.
- Positive Future Outlook: Management anticipates consolidated revenue for 2026 to be between $2.6 billion and $2.7 billion, with gross margin expected between 34% and 35%, reflecting confidence in new product launches and VOXX integration despite risks from tariffs and commodity price volatility.
- Earnings vs Revenue: Gentex Corporation reported fourth-quarter adjusted earnings per share of 43 cents, meeting analyst expectations, but quarterly sales of $644.401 million fell short of the $651.904 million forecast, indicating revenue growth challenges.
- Stable Core Demand: Despite a 2% decline in light-vehicle production across North America, Europe, and Japan/Korea, Gentex's core revenue remained steady at $541 million, demonstrating the company's ability to maintain performance amid market volatility.
- Challenges in China: Gentex's sales in China totaled approximately $34.5 million for the quarter, impacted by tariffs; however, the company offset a 29% year-over-year sales decline in China through increased sales in primary markets, showcasing its market adaptability.
- Future Outlook: Gentex forecasts fiscal 2026 sales between $2.60 billion and $2.70 billion, slightly below analysts' estimate of $2.66 billion, while expecting a consolidated gross margin of 34% to 35%, reflecting a cautious approach to future market conditions.
- Earnings Overview: Gentexpress (GNTX) reported a Q4 2023 GAAP EPS of $0.43, meeting expectations, while revenue reached $644.4 million, a 19.0% year-over-year increase, but fell short of the $654.3 million consensus, indicating revenue growth challenges.
- Gross Margin Insights: The consolidated gross margin stood at 34.8%, with the core Gentex (excluding VOXX) at 35.5%, suggesting that while revenue is growing, cost control measures need to be strengthened to maintain profitability.
- 2026 Financial Guidance: Gentex projects 2026 consolidated revenue between $2.60 billion and $2.70 billion, slightly below the $2.66 billion consensus, with gross margin expectations of 34% to 35%, reflecting a cautious outlook on future growth.
- Operating Expenses and CapEx: Operating expenses, including R&D and SG&A, are expected to range from $410 million to $420 million, while capital expenditures are projected at $125 million to $140 million, indicating strategic planning for future investments and cost management.
- Earnings Announcement: Gentex is scheduled to release its Q4 earnings on January 30 before market open, with a consensus EPS estimate of $0.43, reflecting a 10.3% year-over-year increase, which could positively influence investor sentiment.
- Revenue Growth Expectations: The anticipated revenue for Q4 is $654.24 million, representing a 20.8% year-over-year increase, indicating strong sales performance amid rising market demand, potentially driving stock price appreciation.
- Historical Performance Review: Over the past two years, Gentex has beaten EPS and revenue estimates 63% of the time, showcasing its stable profitability and market adaptability, which enhances investor confidence in future performance.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen four upward revisions and two downward revisions, while revenue estimates have experienced five upward revisions with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.

- Earnings Release Schedule: Gentex Corporation will release its Q4 and Year-End 2025 financial results on January 30, 2026, before market opening, highlighting the company's commitment to transparency and investor communication.
- Conference Call Timing: The company will host a conference call at 9:30 AM ET to discuss the financial results, aiming to enhance interaction with investors and stakeholders.
- Public Participation Channels: The call will be available via a live audio webcast, ensuring all investors can participate, which reflects the company's dedication to information sharing and accessibility.
- Registration and Participation Recommendations: Participants are encouraged to join 10 minutes early, although they can dial in at any time during the call, demonstrating the company's focus on improving the investor experience.








